Cytokinetics Inc. (CYTK) is a publicly traded Healthcare sector company. As of August 11, 2026, CYTK trades at $77.84 with a market cap of $10.42B and a P/E ratio of -10.64. CYTK moved +0.45% today. Year to date, CYTK is +21.95%; over the trailing twelve months it is +127.18%. Its 52-week range spans $29.31 to $88.31. Analyst consensus is strong buy with an average price target of $110.86. Rallies surfaces CYTK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Cytokinetics Inc. (CYTK) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CYTK moved +0.45% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $77.84 |
| Market Cap | $10.42B |
| P/E Ratio | -10.64 |
| EPS | $-7.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $88.31 |
| 52-Week Low | $29.31 |
| Volume | 6.48K |
| Avg Volume | 0 |
| Revenue (TTM) | $67.67M |
| Net Income | $-894.00M |
| Gross Margin | 0.00% |
16 analysts cover CYTK: 0 strong buy, 15 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $110.86.